Gerresheimer AG (GRRMF)
29.05
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Gerresheimer Enterprise Value : 3.440B for Oct. 8, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 3.440B |
| October 07, 2026 | 3.440B |
| October 06, 2026 | 3.440B |
| October 05, 2026 | 3.440B |
| October 02, 2026 | 3.440B |
| October 01, 2026 | 3.440B |
| September 30, 2026 | 3.440B |
| September 29, 2026 | 3.440B |
| September 28, 2026 | 3.440B |
| September 25, 2026 | 3.440B |
| September 24, 2026 | 3.440B |
| September 23, 2026 | 3.440B |
| September 22, 2026 | 3.440B |
| September 21, 2026 | 3.440B |
| September 18, 2026 | 3.548B |
| September 17, 2026 | 3.548B |
| September 16, 2026 | 3.548B |
| September 15, 2026 | 3.548B |
| September 14, 2026 | 3.548B |
| September 11, 2026 | 3.548B |
| September 10, 2026 | 3.548B |
| September 09, 2026 | 3.548B |
| September 08, 2026 | 3.548B |
| September 04, 2026 | 3.548B |
| September 03, 2026 | 3.548B |
| Date | Value |
|---|---|
| September 02, 2026 | 3.548B |
| September 01, 2026 | 3.548B |
| August 31, 2026 | 3.548B |
| August 28, 2026 | 3.548B |
| August 27, 2026 | 3.548B |
| August 26, 2026 | 3.548B |
| August 25, 2026 | 3.548B |
| August 24, 2026 | 3.548B |
| August 21, 2026 | 3.512B |
| August 20, 2026 | 3.512B |
| August 19, 2026 | 3.512B |
| August 18, 2026 | 3.512B |
| August 17, 2026 | 3.512B |
| August 14, 2026 | 3.512B |
| August 13, 2026 | 3.512B |
| August 12, 2026 | 3.512B |
| August 11, 2026 | 3.512B |
| August 10, 2026 | 3.443B |
| August 07, 2026 | 3.443B |
| August 06, 2026 | 3.530B |
| August 05, 2026 | 3.530B |
| August 04, 2026 | 3.530B |
| August 03, 2026 | 3.530B |
| July 31, 2026 | 3.530B |
| July 30, 2026 | 3.500B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Evotec SE | 569.38M |
| Lifecore Biomedical, Inc. | 431.71M |
| Repligen Corp. | 9.126B |
| Bio-Techne Corp. | 11.33B |
| Codexis, Inc. | 141.53M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -126.36M |
| Revenue (Quarterly) | 558.10M |
| Total Expenses (Quarterly) | 684.60M |
| EPS Diluted (Quarterly) | -3.345 |
| Gross Profit Margin (Quarterly) | 10.37% |
| Profit Margin (Quarterly) | -22.64% |
| Earnings Yield | -46.70% |
| Normalized Earnings Yield | -24.79 |